04/25/2024
11:15 PM | Allogene Therapeutics (Filer)
| Form EFFECT | |
04/24/2024
3:18 PM | Allogene Therapeutics (Issuer)
MOORE TIMOTHY L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:31 PM | Allogene Therapeutics (Filer)
| Form DEF 14A | |
04/23/2024
3:32 PM | Allogene Therapeutics (Filer)
| Form DEFA14A | |
04/23/2024
3:33 PM | Allogene Therapeutics (Filer)
| Form ARS | |
04/22/2024
3:09 PM | Allogene Therapeutics (Subject)
MOORE TIMOTHY L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
7:10 PM | Allogene Therapeutics (Issuer)
Chang David D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/14/2024
4:28 PM | Allogene Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/14/2024
4:21 PM | Allogene Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/14/2024
3:51 PM | Allogene Therapeutics (Filer)
| Form POSASR | |
03/14/2024
3:55 PM | Allogene Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/14/2024
3:31 PM | Allogene Therapeutics (Subject)
Chang David D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
8:52 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
7:30 AM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:36 PM | Allogene Therapeutics (Subject)
Belldegrun Arie (Filed by)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Allogene Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/31/2024
4:45 PM | Allogene Therapeutics (Issuer)
Roberts Zachary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:46 PM | Allogene Therapeutics (Issuer)
Belldegrun Arie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:47 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:48 PM | Allogene Therapeutics (Issuer)
Douglas Earl Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:51 PM | Allogene Therapeutics (Issuer)
MOORE TIMOTHY L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:42 PM | Allogene Therapeutics (Issuer)
Chang David D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:25 PM | Allogene Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/24/2024
4:25 PM | Allogene Therapeutics (Issuer)
Roberts Zachary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
9:02 AM | Allogene Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/22/2024
3:11 PM | Allogene Therapeutics (Subject)
Roberts Zachary (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
7:00 AM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
3:26 PM | Allogene Therapeutics (Issuer)
MESSEMER DEBORAH M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
2:46 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
3:17 PM | Allogene Therapeutics (Subject)
MESSEMER DEBORAH M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
3:41 PM | Allogene Therapeutics (Filer)
| Form 424B5 | |
10/25/2023
4:29 PM | Allogene Therapeutics (Subject)
PFIZER INC (Filed by)
| Form SC 13D/A | |
10/17/2023
3:34 PM | Allogene Therapeutics (Filer)
| Form 8-K/A | |
10/16/2023
6:25 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2023
7:31 AM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/17/2023
5:57 PM | Allogene Therapeutics (Issuer)
Douglas Earl Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
1:50 PM | Allogene Therapeutics (Issuer)
Douglas Earl Martin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2023
6:59 PM | Allogene Therapeutics (Issuer)
CHEN YINLIN JACK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
6:28 PM | Allogene Therapeutics (Issuer)
CHEN YINLIN JACK (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
3:04 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
9:20 AM | Allogene Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
The A.I. story nobody is telling you (Read ASAP) (Ad) There's been a lot of buzz surrounding A.I. over the past year...
Most of it is just hype and speculation.
But there's one recent A.I. development you NEED to hear about... Click here to see Louis' new video for yourself. |
06/29/2023
1:08 PM | Allogene Therapeutics (Subject)
Bhavnagri Veer (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2023
3:05 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
3:37 PM | Allogene Therapeutics (Subject)
Bhavnagri Veer (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023
4:02 PM | Allogene Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
4:03 PM | Allogene Therapeutics (Issuer)
Barrett Elizabeth A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
4:06 PM | Allogene Therapeutics (Issuer)
MESSEMER DEBORAH M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
7:04 AM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
6:08 PM | Allogene Therapeutics (Subject)
MOORE ALISON (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
